These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28196313)

  • 1. Executive Functioning at Baseline Prospectively Predicts Depression Treatment Response.
    Dawson EL; Caveney AF; Meyers KK; Weisenbach SL; Giordani B; Avery ET; Schallmo MP; Bahadori A; Bieliauskas LA; Mordhorst M; Marcus SM; Kerber K; Zubieta JK; Langenecker SA
    Prim Care Companion CNS Disord; 2017 Feb; 19(1):. PubMed ID: 28196313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of Intensive Short-Term Dynamic Psychotherapy for treatment resistant depression: the Halifax Depression Study.
    Town JM; Abbass A; Stride C; Bernier D
    J Affect Disord; 2017 May; 214():15-25. PubMed ID: 28266318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of antidepressant treatment of psychiatric patients with depressive disorders: treatment adequacy and outcomes.
    von Knorring J; Baryshnikov I; Jylhä P; Talaslahti T; Heikkinen M; Isometsä E
    BMC Psychiatry; 2023 Nov; 23(1):888. PubMed ID: 38017416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
    Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
    Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMPROVEMENTS IN PSYCHOSOCIAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE FOLLOWING EXERCISE AUGMENTATION IN PATIENTS WITH TREATMENT RESPONSE BUT NONREMITTED MAJOR DEPRESSIVE DISORDER: RESULTS FROM THE TREAD STUDY.
    Greer TL; Trombello JM; Rethorst CD; Carmody TJ; Jha MK; Liao A; Grannemann BD; Chambliss HO; Church TS; Trivedi MH
    Depress Anxiety; 2016 Sep; 33(9):870-81. PubMed ID: 27164293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
    Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
    Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of psychotherapeutic text messaging for depression.
    Pfeiffer PN; Henry J; Ganoczy D; Piette JD
    J Telemed Telecare; 2017 Aug; 23(7):665-672. PubMed ID: 27450571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Breathing-Based Meditation Intervention for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Randomized Pilot Study.
    Sharma A; Barrett MS; Cucchiara AJ; Gooneratne NS; Thase ME
    J Clin Psychiatry; 2017 Jan; 78(1):e59-e63. PubMed ID: 27898207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
    Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
    JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mistreatment of major depressive disorder.
    Paris J
    Can J Psychiatry; 2014 Mar; 59(3):148-51. PubMed ID: 24881163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Supplementary Cognitive-Behavioral Therapy for Pharmacotherapy-Resistant Depression: A Randomized Controlled Trial.
    Nakagawa A; Mitsuda D; Sado M; Abe T; Fujisawa D; Kikuchi T; Iwashita S; Mimura M; Ono Y
    J Clin Psychiatry; 2017; 78(8):1126-1135. PubMed ID: 28252882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic relationship in the treatment of geriatric depression with executive dysfunction.
    Mace RA; Gansler DA; Suvak MK; Gabris CM; Areán PA; Raue PJ; Alexopoulos GS
    J Affect Disord; 2017 May; 214():130-137. PubMed ID: 28288407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early improvement of executive test performance during antidepressant treatment predicts treatment outcome in patients with Major Depressive Disorder.
    Wagner S; Helmreich I; Wollschläger D; Meyer K; Kaaden S; Reiff J; Roll SC; Braus D; Tüscher O; Müller-Dahlhaus F; Tadić A; Lieb K
    PLoS One; 2018; 13(4):e0194574. PubMed ID: 29668746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
    Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
    Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive Dysfunction Predicts Treatment Response to Neuroplasticity-Based Computerized Cognitive Remediation (nCCR-GD) in Elderly Patients with Major Depression.
    Morimoto SS; Gunning FM; Wexler BE; Hu W; Ilieva I; Liu J; Nitis J; Alexopoulos GS
    Am J Geriatr Psychiatry; 2016 Oct; 24(10):816-20. PubMed ID: 27591163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics, management, and depression outcomes of primary care patients who endorse thoughts of death or suicide on the PHQ-9.
    Bauer AM; Chan YF; Huang H; Vannoy S; Unützer J
    J Gen Intern Med; 2013 Mar; 28(3):363-9. PubMed ID: 22936288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9).
    Löwe B; Kroenke K; Herzog W; Gräfe K
    J Affect Disord; 2004 Jul; 81(1):61-6. PubMed ID: 15183601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Prediction Model for Evaluating Treatment-Resistant Depression.
    Kautzky A; Baldinger-Melich P; Kranz GS; Vanicek T; Souery D; Montgomery S; Mendlewicz J; Zohar J; Serretti A; Lanzenberger R; Kasper S
    J Clin Psychiatry; 2017 Feb; 78(2):215-222. PubMed ID: 28068461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.